Global Computational Biology Market is Expected to Grow Revenue up to USD 33,686 Million By 2030 with a Growing CAGR of 23.79% | Infinium Global Research

Infinium Global Research, a leading provider of market intelligence, unveils a comprehensive report analyzing the global and regional Computational Biology Market, showcasing detailed insights into segments and sub-segments. This comprehensive study underscores the impact of drivers, restraints, and macro indicators, offering a profound understanding of short-term and long-term market dynamics. The global computational biology market was valued at USD 6248.7 Million in 2022 and is expected to reach USD 33,686 Million by 2030 and grow at a CAGR of 23.79% over the forecast period.

To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/reports/sample-request/1799

Key Insights from the Report:

Rapid Expansion in Computational Biology: The global computational biology market is forecasted to grow at an impressive CAGR of 23.79% between 2023 and 2030, reflecting a surge in value. Factors such as increased clinical studies in pharmacokinetics, pharmacogenomics, drug designing, and personalized medicine have significantly propelled market growth. Furthermore, the demand for predictive models and robust investments in R&D by governments and private organizations have augmented the market. Despite these advancements, the shortage of trained professionals remains a hurdle for the market's growth.

Geographical Dynamics and Leading Players: North America leads the computational biology market, closely followed by Europe and the Asia-Pacific. Factors like increased R&D investments, technological advancements, and focused studies in the pharmacogenomics and pharmacokinetics domains are driving North America's market dominance. Meanwhile, the Asia-Pacific region is experiencing substantial growth due to rising research expenditures in clinical studies for new drugs.

Innovative Applications in Drug Discovery: Computational biology has significantly revolutionized drug discovery, aiding in molecular pathway modeling, drug efficacy prediction, and analysis of genetic overlaps between diseases. Its multidisciplinary approach helps generate hypotheses, identify novel targets, and design drugs more effectively. Additionally, computational biology facilitates risk assessment and biomarker identification, enhancing innovation and cost-efficiency in the pharmaceutical industry.

Impact on Cancer Treatment and Research: The prevalence of cancer, attributed to changing lifestyles and other factors, has surged globally. Computational biology plays a crucial role in understanding the disease and discovering new therapies. Its application enables the collection and analysis of vast genomic, gene expression, and histopathology data, providing more effective treatments tailored to individual patients.

Challenges and Opportunities: Despite its pivotal role, the deficiency in computational biology expertise remains a challenge. There's a significant shortage of skilled professionals capable of analyzing vast biological data, impacting hiring costs and profitability. However, significant investments from federal agencies like NIH and private tech giants are bolstering initiatives, fostering the growth of the computational biology market.

Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/reports/customization/1799

Table of Content

Chapter 1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

Chapter 2. Executive Summary

2.1. Computational Biology Market Highlights

2.2. Computational Biology Market Projection

2.3. Computational Biology Market Regional Highlights

Chapter 3. Global Computational Biology Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Analysis of COVID-19 impact on the Computational Biology Market

3.4. Porter's Five Forces Analysis

3.5. IGR-Growth Matrix Analysis

3.5.1. IGR-Growth Matrix Analysis by Application

3.5.2. IGR-Growth Matrix Analysis by Service

3.5.3. IGR-Growth Matrix Analysis by End User

3.5.4. IGR-Growth Matrix Analysis by Region

3.6. Value Chain Analysis of Computational Biology Market

Chapter 4. Computational Biology Market Macro Indicator Analysis

Chapter 5. Global Computational Biology Market by Application

5.1. Human Body Simulation Software

5.2. Preclinical Drug Development

5.3. Cellular & Biological Simulation

5.4. Clinical Trials

5.5. Drug Discovery

5.6. Disease Modelling

Chapter 6. Global Computational Biology Market by Service

6.1. In-house

6.2. Contract

Chapter 7. Global Computational Biology Market by End User

7.1. Academics

7.2. Commercial

Chapter 8. Global Computational Biology Market by Region 2023-2030

8.1. North America

8.1.1. North America Computational Biology Market by Application

8.1.2. North America Computational Biology Market by Service

8.1.3. North America Computational Biology Market by End User

8.1.4. North America Computational Biology Market by Country

8.2. Europe

8.2.1. Europe Computational Biology Market by Application

8.2.2. Europe Computational Biology Market by Service

8.2.3. Europe Computational Biology Market by End User

8.2.4. Europe Computational Biology Market by Country

8.3. Asia-Pacific

8.3.1. Asia-Pacific Computational Biology Market by Application

8.3.2. Asia-Pacific Computational Biology Market by Service

8.3.3. Asia-Pacific Computational Biology Market by End User

8.3.4. Asia-Pacific Computational Biology Market by Country

8.4. RoW

8.4.1. RoW Computational Biology Market by Application

8.4.2. RoW Computational Biology Market by Service

8.4.3. RoW Computational Biology Market by End User

8.4.4. RoW Computational Biology Market by Sub-region

Chapter 9. Company Profiles and Competitive Landscape

9.1. Competitive Landscape in the Global Computational Biology Market

9.2. Companies Profiles

9.2.1. Chemical Computing Group Inc.

9.2.2. Genedata AG

9.2.3. Nimbus Discovery Llc

9.2.4. Simulation Plus Inc

9.2.5. Dassault Systemes

9.2.6. Compugen Ltd

9.2.7. Rosa & Co. LLC

9.2.8. Insilico Biotechnology AG

9.2.9. Schrodinger

9.2.10. Leadscope Inc.

More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/reports/enquiry/1799

Reasons to Buy this Report:

=> Comprehensive analysis of global as well as regional markets of Computational Biology.

=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.

=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.

=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.

2nd Floor, Ganadish Empire, Rahatani Chowk, Pimple Saudagar, Pimpri-Chinchwad, Maharashtra 411027

About Infinium Global Research:

Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.
Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.

This release was published on openPR.